Krystal Biotech Inc., (?Krystal?) (NASDAQ: KRYS), a fully integrated gene therapy company driven by its proprietary, engineered herpes simplex virus t
more on businesswire.com
Krystal Biotech Inc., (?Krystal?) (NASDAQ: KRYS), a fully integrated gene therapy company driven by its proprietary, engineered herpes simplex virus t